These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19234610)

  • 1. Probing evolutionary repeatability: neutral and double changes and the predictability of evolutionary adaptation.
    Roy SW
    PLoS One; 2009; 4(2):e4500. PubMed ID: 19234610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network models of TEM β-lactamase mutations coevolving under antibiotic selection show modular structure and anticipate evolutionary trajectories.
    Guthrie VB; Allen J; Camps M; Karchin R
    PLoS Comput Biol; 2011 Sep; 7(9):e1002184. PubMed ID: 21966264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Fitness of Beta-Lactamase Mutants Depends Nonlinearly on Resistance Level at Sublethal Antibiotic Concentrations.
    Farr AD; Pesce D; Das SG; Zwart MP; de Visser JAGM
    mBio; 2023 Jun; 14(3):e0009823. PubMed ID: 37129484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation supply and the repeatability of selection for antibiotic resistance.
    van Dijk T; Hwang S; Krug J; de Visser JAGM; Zwart MP
    Phys Biol; 2017 Aug; 14(5):055005. PubMed ID: 28699625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental changes bridge evolutionary valleys.
    Steinberg B; Ostermeier M
    Sci Adv; 2016 Jan; 2(1):e1500921. PubMed ID: 26844293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial mutations direct alternative pathways of protein evolution.
    Salverda ML; Dellus E; Gorter FA; Debets AJ; van der Oost J; Hoekstra RF; Tawfik DS; de Visser JA
    PLoS Genet; 2011 Mar; 7(3):e1001321. PubMed ID: 21408208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme Efficiency but Not Thermostability Drives Cefotaxime Resistance Evolution in TEM-1 β-Lactamase.
    Knies JL; Cai F; Weinreich DM
    Mol Biol Evol; 2017 May; 34(5):1040-1054. PubMed ID: 28087769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Darwinian evolution can follow only very few mutational paths to fitter proteins.
    Weinreich DM; Delaney NF; Depristo MA; Hartl DL
    Science; 2006 Apr; 312(5770):111-4. PubMed ID: 16601193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptive benefits from small mutation supplies in an antibiotic resistance enzyme.
    Salverda MLM; Koomen J; Koopmanschap B; Zwart MP; de Visser JAGM
    Proc Natl Acad Sci U S A; 2017 Nov; 114(48):12773-12778. PubMed ID: 29133391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolutionary accessibility of mutational pathways.
    Franke J; Klözer A; de Visser JA; Krug J
    PLoS Comput Biol; 2011 Aug; 7(8):e1002134. PubMed ID: 21876664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SHV-129: A Gateway to Global Suppressors in the SHV β-Lactamase Family?
    Winkler ML; Bonomo RA
    Mol Biol Evol; 2016 Feb; 33(2):429-41. PubMed ID: 26531195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mistranslation can promote the exploration of alternative evolutionary trajectories in enzyme evolution.
    Zheng J; Bratulic S; Lischer HEL; Wagner A
    J Evol Biol; 2021 Aug; 34(8):1302-1315. PubMed ID: 34145657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bypass of genetic constraints during mutator evolution to antibiotic resistance.
    Couce A; Rodríguez-Rojas A; Blázquez J
    Proc Biol Sci; 2015 Apr; 282(1804):20142698. PubMed ID: 25716795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal constraints on the incorporation of regulatory mutants in evolutionary pathways.
    Brown KM; Depristo MA; Weinreich DM; Hartl DL
    Mol Biol Evol; 2009 Nov; 26(11):2455-62. PubMed ID: 19602543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Empirical fitness landscapes and the predictability of evolution.
    de Visser JA; Krug J
    Nat Rev Genet; 2014 Jul; 15(7):480-90. PubMed ID: 24913663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the emergence of antibiotic resistance by directed evolution and structural analysis.
    Orencia MC; Yoon JS; Ness JE; Stemmer WP; Stevens RC
    Nat Struct Biol; 2001 Mar; 8(3):238-42. PubMed ID: 11224569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying the Determinants of Evolutionary Dynamics Leading to Drug Resistance.
    Chevereau G; Dravecká M; Batur T; Guvenek A; Ayhan DH; Toprak E; Bollenbach T
    PLoS Biol; 2015; 13(11):e1002299. PubMed ID: 26581035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mistranslation can enhance fitness through purging of deleterious mutations.
    Bratulic S; Toll-Riera M; Wagner A
    Nat Commun; 2017 May; 8():15410. PubMed ID: 28524864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolutionary potential of an RNA virus.
    Makeyev EV; Bamford DH
    J Virol; 2004 Feb; 78(4):2114-20. PubMed ID: 14747576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shifting Fitness and Epistatic Landscapes Reflect Trade-offs along an Evolutionary Pathway.
    Steinberg B; Ostermeier M
    J Mol Biol; 2016 Jul; 428(13):2730-43. PubMed ID: 27173379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.